Table 2.
First Author, Year | Models | UT(s) Studied | Main Findings |
---|---|---|---|
Atheromatous CVDs | |||
Arinze [50], 2022 | Adenine-induced | IS | IS, kynurenine, and KA suppressed Wnt/- |
CKD mice and IS so- | Kynurenine | catenin signaling through increased AHR activity, | |
lute-specific C57BL/6 | KA | leading to impaired angiogenesis and hindlimb | |
mice | ischemia. | ||
Hung [101], 2016 | Mice with subtotal nephrectomy | IS | IS decreased endothelial progenitor cells mobilization and impaired neovascularization, leading to PAD. |
Han [103], 2016 | 5/6 nephrectomized ApoE –/– mice | PCS | PCS promoted the formation of atherosclerotic lesions, induced plaque instability and the migration and proliferation of VSMCs, and disturbed the balance between matrix metalloproteinases and tissue inhibitor of metalloproteinases within the plaques. |
Huang [60], 2018 | 5/6 nephrectomized rat model | HA | HA caused pro-atherogenic effects by contributing to endothelial dysfunction via greater oxidative stress and impaired endothelium-dependent vasodilation. |
Shang [61], 2017 | Male Wistar rats | HA | HA induced miR-92a, which is involved in angiogenic and atherosclerotic processes. |
Massy [107], 2005 | ApoE −/− mice with partial kidney ablation | Urea | Urea contributed to arterial calcification and aggravated atherosclerosis. |
Matsumoto [102], 2020 | Superior mesenteric arteries and femoral arteries of rat | TMAO | TMAO impaired endothelium-derived hyperpolarizing factor-type relaxation, which led to PAD. |
Geng [104], 2018 | Apoe −/− mice fed a high-fat diet with or without TMAO | TMAO | TMAO enhanced the expression of CD36/MAPK/JNK pathway, promoting foam cells formation and, ultimately, atherosclerosis. |
Seldin [105], 2016 | Female low-density lipoprotein receptor knockout mice injected with vehicle or TMAO | TMAO | TMAO induced vascular inflammation by activating MAPK and NF-B signaling, thus enhancing atherosclerosis. |
Koeth [106], 2013 | Mice supplemented with dietary TMAO, carnitine, or choline | TMAO | TMAO accelerated atherosclerosis and was linked to major cardiac events. |
Non-atheromatous CVDs | |||
Kuo [108], 2020 | Nephrectomized male C57BL/6 mice | IS | IS promoted calcification in the aorta and peripheral arteries, with low NO production and high eNOS phosphorylation. |
Opdebeeck [109], 2019 | 42 male Wistar rats ex- | IS | Both IS and PCS directly promoted severe calcifica- |
posed to adenine sulfate for 10 days and then fed a phosphate-enriched diet | PCS | tion in the aorta and peripheral vessels via activation of inflammation and coagulation pathways. These changes were strongly associated with impaired glucose homeostasis. | |
Chen [81], 2016 | 5/6 nephrectomized Sprague Dawley rats treated with IS | IS | IS decreased Klotho expression and promoted aortic calcification. |
Chen [121], 2015 | Isolated rabbit left atrium, right atrium, pulmonary vein, and sinoatrial nodes before and after treatment with IS | IS | IS may contribute to atrial fibrillation: It increased pulmonary vein and atrial arrhythmogenesis through oxidative stress, inflammation, and fibrosis. |
Yisireyili [119], 2013 and Lekawanvijit [120], 2012 | Dahl salt-sensitive hypertensive rats | IS | IS aggravated cardiac fibrosis and cardiomyocyte hypertrophy, with greater levels of oxidative stress and lower anti-oxidative defenses. |
Muteliefu [110], 2012 | Aorta of subtotally nephrectomized Dahl salt-sensitive hypertensive rats | IS | IS accelerated VSMC senescence and vascular calcification, with upregulation of p21, p53, and prelamin A through oxidative stress. |
Adijiang [111], 2010 | Dahl salt-sensitive hypertensive rats | IS | IS increased aortic calcification and wall thickness; induced expression of p16, p21, p53 and Rb in the calcification area; and thus promoted cell senescence. |
Adijiang [112], 2008 | Dahl salt-sensitive hypertensive rats | IS | IS induced aortic calcification (with expression of osteoblast-specific proteins) and aortic wall thickening. |
Han [126], 2015 | 5/6 nephrectomized mice | PCS | PCS promoted cardiac apoptosis and diastolic dysfunction by upregulating the expression of NADPH oxidase and the production of ROS. |
Hu [123], 2015 | Two CKD rodent models: UNX-IRI26 and 5/6 nephrectomized | Phosphate | High phosphate was associated with lower Klotho levels, leading to cardiac hypertrophy and fibrosis. |
Yamada [116], 2014 | Adenine-induced CKD male Sprague–Dawley rats | Phosphate | High phosphate directly increased the expression of TNF- and osteochondrogenic markers, inducing systemic inflammation and vascular calcification. |
Lau [114], 2013 | DBA/2 mice with partial renal ablation | Phosphate | High phosphate was associated with arterial medial calcification. |
Crouthamel [113], 2013 | Mice with targeted deletion of PiT-1 in VSMCs | Phosphate | High phosphate induced calcification of VSMCs. |
El-Abbadi [115], 2009 | Female DBA/2 mice induced uremia with left total nephrectomy | Phosphate | High phosphate was associated with extensive arterial medial calcification. |
Graciolli [117], 2009 | 5/6 nephrectomized Wistar rats with parathyroidectomy | Phosphate | Phosphate upregulated aortic expression of Runx2 and led to calcified VSMC. |
Hosaka [118], 2009 | 5/6 nephrectomized male Sprague-Dawley rats | Phosphate | High phosphate induced elastin degradation via the upregulation of tissue-nonspecific alkaline phosphatase, accelerating the transformation of VSMCs into osteoblast-like cells and leading to medial layer calcification. |
Zhu [122], 2021 | 25 nephrectomized SPF-grade male Sprague–Dawley rats | Urea | Urea caused myocardial hypertrophy. |
Prommer [124], 2018 | 11 uremic mice and 8 controls | Urea | Urea led to systemic microvascular disease, with microvascular rarefaction, tissue hypoxia, and dysfunctional angiogenesis. |
Carmona [125], 2011 | 2 groups of 30 Wistar male rats: 1 with renal ablation and the other with kidney manipulation only | Urea | Urea induced systemic inflammation and led to the thickening of subepicardiac arteries. |
Other than ATH and non ATH CVDs | |||
Yang [127], 2017 | C57BL/6J mice with left total nephrectomy | IS | IS activated ROS/p38 MAPK signaling and reduced Klotho expression, which induced platelet aggregation and thrombus formation. |
Kolachalama [128], 2018 | A group of C57BL/6 mice administered Kyn, the excretion of which was inhibited by probenecid | Kynurenine | High kynurenine levels promoted clotting in response to vascular injury. |
Koppe [133], 2017 | 5/6 nephrectomized | PCS | PCS (but not PCG) promoted insulin resistance. |
mice | PCG | ||
Koppe [134], 2013 | CD1 Swiss and C57BL/6J mice with 5/6 nephrectomy | PCS | PCS contributed to insulin resistance: It altered insulin signaling in skeletal muscle through the activation of extracellular signal-regulated kinases. |
Nagy [97], 2017 | Male CD1 mice injected with CMPF | CMPF | CMPF inhibited insulin secretion. |
Koppe [130], 2016 | C57BL/6N male mice with 5/6 nephrectomy | Urea | Urea increased oxidative stress and protein O-GlcNAcylation, impairing insulin secretion and glycolysis. |
Carracedo [131], 2013 | 5/6 nephrectomized 40 male Wistar rats | Urea | Urea induced oxidative stress, leading to EC damage. |
D’Apolito [98], 2010 | 5/6 nephrectomized C57BL/6J wild-type mice | Urea | Urea increased ROS production and induced insulin resistance and glucose intolerance. |
Li [132], 2018 | 5/6 nephrectomized rats | TMAO | High TMAO levels decreased NO production, contributing to endothelial dysfunction. |
Zhu [129], 2016 | Carotid artery thrombosis models of germ-free C57BL/6J female mice | TMAO | TMAO enhanced submaximal stimulus-dependent platelet activation, increasing the thrombosis risk. |
Abbreviations: CMPF: 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid; CVD: cardiovascular disease; eNOS:endothelial nitric oxide synthase; HA: hippuric acid; IS:indoxyl sulfate; KA: kynurenic acid; MAPK: mitogen-activated protein kinase; MI: myocardial infarction; NADPH: nicotinamide adenine dinucleotide phosphate; NO: nitric oxide; PAD: peripheral artery disease; PCS: para-cresyl sulfate; PCG: p-cresyl glucuronide; ROS: reactive oxygen species; Runx2: runt-related transcription factor 2; TMAO: trimethylamine-N-oxide; UT: uremic toxin; VSMC: vascular smooth muscle cell.